UnitedHealth Group (NYSE: UNH) signaled confidence in its merger with Amedisys (Nasdaq: AMED) in a document prepared for shareholders. An earlier draft of ...

UnitedHealth Group is suing The Guardian for defamation following the publication of an investigative report from the British media outlet that accuses the company of engaging in harmful and ...

In the latest trading session, UnitedHealth Group (UNH) closed at $300.38, marking a -0.28% move from the previous day. This change lagged the S&P 500's daily gain of 0.01%. Elsewhere, the Dow lost 0.

A bill aimed at increasing transparency in how pharmacy benefit managers operate advanced out of the Senate Insurance Committee Wednesday, signaling a push to regulate an industry that critics say ...

Editorial written by Boston Herald Editorial Board Anti-Trump resistance has sunk to a new low. An employee of the Defense Intelligence Agency is accused of attempting to share classified material ...

Simultaneously, AM Best has revised the outlook to negative from stable and affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of “aa-” (Superior) for the health and ...

On June 3, Bernstein SocGen Group analysts reiterated an ‘Outperform’ rating on Humana Inc. (NYSE: HUM) and a $313 price ...

UnitedHealth Group prepared talking points for its shareholder meeting this week. The company published them Wednesday after ...

Wedbush star tech analyst Dan Ives, known for his bullish AI thesis, see his namesake exchange-traded-fund launch today.

UnitedHealth raised its dividend and replaced its CEO amid scrutiny over Medicare billing and a nearly 40% stock decline this year.

UnitedHealth stock has crashed some 50% amidst a cascade of bad news. Cavenagh Research says UNH shares could tumble further.

Clinical: Medical Real Estate Solutions continues its launch, debuting an affiliated consulting group led by a pair of ...